Management of Children with Pericardial Effusion after COVID-19 on Outpatient Level of Service-Reference-Cited by-同舟云学术

Management of Children with Pericardial Effusion after COVID-19 on Outpatient Level of Service

Published:2022-07-13 Issue:3 Volume:19 Page:263-268
ISSN:2500-3089
Container-title:Pediatric pharmacology
language:
Short-container-title:Pediatr. farmakol.

Author:

Martakov Mikhail A.¹^ORCID,Rusinova Dina S.²^ORCID,Bezymyanny Alexey S.³^ORCID,Mogutnova Nadezda F.⁴,Marushko Pavel N.¹,Shevchenko Irina A.¹

Affiliation:

1. Children’s City Outpatient’s Clinic № 133 of Moscow City Health Department

2. Children’s City Outpatient’s Clinic № 133 of Moscow City Health Department; Pirogov Russian National Research Medical University

3. Moscow Healthcare Department; Directorate for Coordination of Medical Facilities of Moscow Healthcare Department

4. Pirogov Russian National Research Medical University

Abstract

The steady increase in the number of people infected with SARS-CoV-2 virus causing COVID-19 all over the world necessitates further study of fundamental features of pandemic spreading and clinical signs of disease, especially in children population. This article presents the experience of managing patients with pericardial effusion that has developed after new coronavirus infection COVID-19. The role of timely diagnosis of pericardial effusion, principles of its diagnostics, management, and follow-up observation on outpatient level within the pandemic are presented.

Publisher

Paediatrician Publishers LLC

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference23 articles.

1. Namazova-Baranova LS. Coronaviral Infection (COVID-19) in Children (Situation on April 2020). Pediatricheskaya farmakologiya — Pediatric pharmacology. 2020;17(2):85–94. (In Russ). doi: https://doi.org/10.15690/pf.v17i2.2094

2. Namazova-Baranova LS, Baranov AA. Coronaviral Infection (COVID-19) in Children (Situation on June 2020). Pediatricheskaya farmakologiya — Pediatric pharmacology. 2020;17(3):162–178. (In Russ). doi: https://doi.org/10.15690/pf.v17i3.2121

3. Rusinova DS, Nikonov EL, Namazova-Baranova LS, et al. Primary Observational Results on Children Who Have Been Exposed to COVID-19 in Moscow. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2020;17(2):95–102. (In Russ). doi: https://doi.org/10.15690/pf.v17i2.2095

4. Alexandrovich YuS, Baybarina EN, Baranov AA, et al. Management of Children with Disease Caused by New Coronaviral Infection (SARS-CoV-2). Pediatricheskaya farmakologiya — Pediatric pharmacology. 2020;17(2):103–118. (In Russ). doi: https://doi.org/10.15690/pf.v17i2.2096

5. Rusinova DS, Martakov MA, Medoev SB, et al. Right Internal Carotid Artery and Basilar Artery Aneurysms After New Coronavirus Infection COVID-19 in Adolescent: Clinical Case. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2021;18(5):385–391. (In Russ). doi: https://doi.org/10.15690/pf.v18i5.2329